JILL KOEPPEN: Open Payments
NPI 1427042027 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,899 in 100 payments from 25 companies in 2025. Trend: 2023 $2,265 · 2024 $2,273 · 2025 $1,899
Food & beverage: $1,899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $271 |
| Novo Nordisk Inc | 12 | $222 |
| PFIZER INC. | 11 | $202 |
| Astellas Pharma US Inc | 5 | $147 |
| Bausch Health US, LLC | 7 | $139 |
| Lilly USA, LLC | 7 | $131 |
| Corium, LLC | 5 | $105 |
| Lundbeck LLC | 4 | $83 |
| Exact Sciences Corporation | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
Products named: Veozah, QULIPTA, Wegovy, MOUNJARO, APLENZIN, VRAYLAR, Azstarys, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
